3 Drug Stocks That Could Win From Key FDA Approvals in June

3 Drug Stocks That Could Win From Key FDA Approvals in June

Submitted by admin on June 4, 2019 - 10:59am
Source: 
Motley Fool
News Tags: 
Merck
Amag Pharmaceuticals
Alexion Pharma
FDA
Keytruda
Vyleesi
Soliris
Headline: 
3 Drug Stocks That Could Win From Key FDA Approvals in June
snippet: 

Three companies that are on track to score major FDA approvals in June are Merck (NYSE: MRK), AMAG Pharmaceuticals (NASDAQ: AMAG), and Alexion Pharmaceuticals (NASDAQ: ALXN). Here's what could be just around the corner for these drugmakers.

Do Not Allow Advertisers to Use My Personal information